Peroxisome proliferator activated receptor-α agonists suppress transforming growth factor-α-induced matrix metalloproteinase-9 expression in human keratinocytes

Clinical and Experimental Dermatology

Volumn 36, Issue 8, 2011, Pages 911-914

  Meissner, M ^a   Berlinski, B ^a   Gille, J ^a   Doll, M ^a   Kaufmann, R ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TRANSFORMING GROWTH FACTOR ALPHA;

3' UNTRANSLATED REGION; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; SKIN METASTASIS; SKIN TUMOR;

ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; POLYMERASE CHAIN REACTION; PPAR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 81255161613     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04125.x     Document Type: Article

References (10)

1. Hanley K, Kömüves LG, Ng DC, et al. Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. J Biol Chem 2000; 275: 11484-91. (Pubitemid 30212804)
2. Kippenberger S, Loitsch SM, Grundmann-Kollmann M, et al. Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation. J Invest Dermatol 2001; 117: 1430-6. (Pubitemid 34032769)
3. Kömüves LG, Hanley K, Man MQ, et al. Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol 2000; 115: 361-7. Chem 275: 11484-91.
4. Hanley K, Jiang Y, Crumrine D, et al. Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 1997; 100: 705-12. (Pubitemid 27340520)
5. Michalik L, Feige JN, Gelman L, et al. Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing. Mol Endocrinol 2005; 19: 2335-48. (Pubitemid 41252826)
6. Sheu MY, Fowler AJ, Kao J, et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118: 94-101. (Pubitemid 34107429)
7. Manicone AM, McGuire JK,. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008; 19: 34-41. (Pubitemid 350235986)
8. Eberhardt W, Akool el-S, Rebhan J, et al. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability. J Biol Chem 2002; 277: 33518-28. (Pubitemid 34984875)
9. Meissner M, Hrgovic I, Doll M, et al. Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner. J Biol Chem 2010; 285: 33797-804.
10. Fähling M, Steege A, Perlewitz A, et al. Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochim Biophys Acta 2005; 1731: 1.